THE FLIPPED CLASSROOM: MEDIA HYPE OR EMPIRICALLY BASED EFFECTIVENESS? von Weiß, Lars-Frederik, Friege, Gunnar

Volltext

BIOCOMPATIBILITY AND TOLERABILITY OF A PURELY BICARBONATE-BUFFERED PERITONEAL DIALYSIS SOLUTION von WEISS, Lars, STEGMAYR, Bernd, VAN HAMERSVELT, Henk W, JOHANSSON, Ann C, HYLANDER, Britta, MAYR, Michael, NILSSON, Per-Henrik, ANDERSSON, Per O, DE LOS RIOS, Tatiana, MALMSTEN, Gudrun, TEJDE, Mattias, HADIMERI, Henrik, SIEGERT, Carl E, AHLMEN, Jarl, LARSSON, Rutger, INGMAN, Bo, SIMONSEN, Ole

Volltext

The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: results from a randomized controlled multicentre trial von Weiss, Lars G., Clyne, Naomi, Fihlho, Jose Divino, Frisenette‐Fich, Carsten, Kurkus, Jan, Svensson, Birgitta

Volltext

Once-weekly erythropoietic therapy: is there a difference between the available preparations? von Weiss, Lars G

Volltext

Confirmation of Nosocomial Transmission of Hepatitis C Virus by Phylogenetic Analysis of the NS5-B Region von NORDER, H, BERGSTRÖM, A, UHNOO, I, ALDEN, J, WEISS, L, CZAJKOWSKI, J, MAGNIUS, L

Volltext

Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis von Attman, Per-Ola A., Samuelsson, Ola G., Moberly, James, Johansson, Ann-Cathrine, Ljungman, Susanne, Weiss, Lars G., Knight-Gibson, Carolyn, Alaupovic, Petar

Volltext

Treatment of hypertension in chronic kidney disease von Weiss, Lars

Volltext

Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products von Rippe, Bengt, Simonsen, Ole, Heimbürger, Olle, Christensson, Anders, Haraldsson, Börje, Stelin, Gunnar, Weiss, Lars, Nielsen, Finn.-David, Bro, Susanne, Friedberg, Michael, Wieslander, Anders

Volltext

Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension: The Nordic Diltiazem Study von Färbom, Patrik, Wahlstrand, Björn, Almgren, Peter, Skrtic, Stanko, Lanke, Jan, Weiss, Lars, Kjeldsen, Sverre, Hedner, Thomas, Melander, Olle

Volltext

A rationale for an individualized administration frequency of epoetin β: a clinical perspective von WEISS, Lars

Volltext

Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency von SAMUELSSON, O, ATTMAN, P.-O, KNIGHT-GIBSON, C, LARSSON, R, MULEC, H, WEISS, L, ALAUPOVIC, P

Volltext

Flexible dosing schemes for recombinant human erythropoietin—lessons from our daily practice von WEISS, Lars

Volltext

Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency von Samuelsson, Ola, Attman, Per-Ola, Knight-Gibson, Carolyn, Mulec, Henrik, Weiss, Lars, Alaupovic, Petar

Volltext

Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease von Samuelsson, Ola, Attman, Per-Ola, Larsson, Rutger, Mulec, Henrik, Rymo, Lars, Weiss, Lars, Ricksten, Anne

Volltext

Which EPO dose per week? [V. Varia Letters and Replies] von Jones, Colin H., Ridley, Lynn, Richardson, Donald, Weiss, Lars

Volltext

Is the use of subcutaneous epoetin β once a week really equivalent to a more frequent administration of the same total dose? [Letters and Replies] von Andrulli, Simeone, D'Amico, Marco, Locatelli, Francesco, Weiss, Lars G.

Volltext

Fräls oss ifrån ondo

Volltext bestellen

Do High-flux Dialysis Membranes Affect Renal Dyslipidemia? von Ottosson, Pia, Attman, Per-Ola, Knight, Carolyn, Samuelsson, Ola, Weiss, Lars, Alaupovic, Petar

Volltext

Cost-effective prevention of renal failure in type 2 diabetics using losartan von Jönsson, Linus, Carides, George W, Burke, Thomas A, Brandt, Ann-Sof ie, Salonen, Tapani, Schön, Staffan, Weiss, Lars

Volltext

Replik om subventionering av läkemedel mot högt blodtryck: Problemet är en enastående underbehandling av hypertoni von Willenheimer, Ronnie, Nyström, Fredrik, Berggren, Bosse, Lindström, Torbjörn, Cizinsky, Stella, Weiss, Lars

Volltext